Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India

Indian Journal of Medical Research

Volumn 117, Issue APR., 2003, Pages 152-157

  Joshi, S ^a   Joglekar, N ^a   Ghate, M ^a   Unni, J ^b   Risbud, A ^a   Bentley, M ^c   Shepherd, M ^d   Bollinger, R ^d   Mehendale, S ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b JEHANGIR HOSPITAL   (India)

^c UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Colposcopy; Microbicides; Nonoxyno 9; Phase I

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE; CLOTRIMAZOLE; NONOXINOL 9;

ABRASION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COLPOSCOPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOXICITY; ERYTHEMA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION; INFECTION RISK; PHASE 1 CLINICAL TRIAL; PROTECTION; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; TREATMENT PLANNING; UTERINE CERVIX; VAGINA DISEASE; VAGINA PESSARY; VIRUS TRANSMISSION; VULVA;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS; COLPOSCOPY; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INDIA; NONOXYNOL; PESSARIES; RISK FACTORS;

EID: 0142106423     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. National AIDS Control Organisation (NACO). Changing epidemiology of AIDS in India. Country Scenario 1997-98. New Delhi: National AIDS Control Organisation; 1998 p. 19.
2. Joint United Nations AIDS Program on HIV/AIDS. Report on the Global HIV/AIDS Epidemic, June 2000. Geneva: UNAIDS; 2000 p. 12.
3. Padian N, Marquis L, Francis DP, Anderson RE, Rutherford GW, O'Malley PM, et al. Male-to-female transmission of human immunodeficiency virus. JAMA 1987; 258 : 788-90.
4. De Bruyn M. Women and AIDS in developing countries. Soc Sci Med 1992; 34 : 249-62.
5. Gangakhedkar RR, Bentley ME, Divekar AD, Gadkari DA, Mehendale SM, Shepherd ME, et al. Spread of HIV infection in married monogamous women in India. JAMA 1997; 278 : 2090-2.
6. Mehendale SM, Shepherd ME, Divekar AD, Gangakhedkar RR, Kamble SS, Menon PA et al. Evidence for high prevalence and rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian J Med Res 1996; 104 : 327-35.
7. Elias CJ, Heise L.L. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994; 8 : 1-9
8. Cates W, Stewart FH, Trussell J. Commentary: The quest for women's prophylactic methods - Hopes vs science. Am J Public Health 1992; 82 : 1479-82.
9. Rosenberg MJ, Gollub EL. Commentary: Methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992: 82 : 1473-8.
10. Stein ZA. HIV prevention: The need for methods women can use. Am J Public Health 1990; 80 : 460-2.
11. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10 (Suppl 3) : S43-51.
12. Rustomjee R, Karim QA, Kasim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS 1999; 13 : 1511-5.
13. Rosenberg MJ, Rojanapitayakorn W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhoea and candidiasis: A comparative clinical trial. JAMA 1987; 257 : 2308-12.
14. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339 : 504-510.
15. Centers for Disease Control and Prevention. CDC statement on study results of product containing nonoxynol-9. MMWR 2000; 49 : 717-8.
16. Manual for the Standardization of Colposcopy for the Evaluation of Vaginally Administered Products. Geneva: World Health Organization; 1995.
17. Bentley M, Morrow K, Fullem A, Chesney MA, Horton SD, Rosenberg Z, et al. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect 2000; 32 : 184-8.
18. Priestley CJF, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med 1997; 73 : 23-8.
19. Keane FEA, Ison CA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997; 8 : 489-94.
20. Fraser IS, Lahteenmaki P, Elomaa K, Lacarra M, Mishell DR Jr, Alvarez F, et al. Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women. Human Reprod 1999; 14 : 1974-8.
21. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991; 18 : 176-9.
22. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4 : 165-70.
23. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339 : 1371-5.
24. Van Damme L, Chandeying V, Ramjee G, Rees H, Sirivongrangson P, Laga M, et al. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group. AIDS 2000; 14 : 85-88.
25. Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, et al. Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17 : 327-31.